Eribulin Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC)
Clinical trial NCT04517292 · UNKNOWN
Trial details
- NCT number
- NCT04517292
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-08
- Primary completion
- 2022-07-30
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.